Ezetimibe (Zetia): Uses, Side Effects, Cost

What is ezetimibe (Zetia)?

Ezetimibe is a prescription pill that lowers LDL cholesterol (the "bad" cholesterol that builds plaque in arteries) by blocking cholesterol absorption in the small intestine. Zetia is the original brand name, and generic ezetimibe contains the same active ingredient.

You take one 10 mg tablet a day. The FDA label approves it alongside a statin, or on its own when other LDL-lowering treatment isn't possible, for adults with high cholesterol, including people with familial hypercholesterolemia (Zetia prescribing information, DailyMed).

If you've been told your LDL is "almost there" on a statin, ezetimibe is very often the next step.

How does ezetimibe work?

Ezetimibe blocks a cholesterol transporter called NPC1L1 in the lining of the small intestine, so less cholesterol from food and bile gets absorbed. With less cholesterol arriving from the gut, the liver pulls more LDL out of the blood to make up the difference.

Statins work at a different point: they slow the liver's own cholesterol production. So the two combine well. One cuts supply from the gut, the other cuts supply from the liver, and the effects add up.

Ezetimibe belongs to its own drug class, separate from both statins and PCSK9 inhibitors.

How much does ezetimibe lower LDL?

On its own, ezetimibe lowers LDL by about 18%, and added to a statin it lowers LDL by about 21 percentage points more than placebo does. The label says the full or near-full effect usually arrives within 2 weeks.

The numbers come from the trials in the FDA label (DailyMed):

• Alone: in two 12-week trials of 1,719 people, LDL fell 18% on ezetimibe and rose 1% on placebo.
• Added to a statin someone was already taking: LDL fell 25% with ezetimibe added, compared with 4% when placebo was added.

The 2026 ACC/AHA multisociety cholesterol guideline puts it in context: ezetimibe lowers LDL by about 15 to 20%, compared with about 60% for a PCSK9 inhibitor (ACC). So it lowers LDL modestly, which often suits someone 20 mg/dL from their target.

Does ezetimibe prevent heart attacks?

Yes, when added to a statin. In the IMPROVE-IT trial, adding ezetimibe to simvastatin after a heart attack or unstable angina lowered the 7-year rate of cardiovascular events from 34.7% to 32.7%.

IMPROVE-IT enrolled 18,144 people hospitalized for an acute coronary syndrome and followed them for a median of 6 years. Average LDL-C was 53.7 mg/dL on simvastatin plus ezetimibe and 69.5 mg/dL on simvastatin alone. The combined rate of cardiovascular death, heart attack, unstable angina needing hospitalization, artery-opening procedures, or stroke was 6.4% lower in relative terms (hazard ratio 0.936), a 2.0 percentage point absolute difference. Muscle, gallbladder, liver, and cancer side effects were similar in both groups.

IMPROVE-IT also showed that pushing LDL below the old targets with a nonstatin drug still prevented events. That fits the larger body of evidence: across 26 statin trials, each 39 mg/dL (1 mmol/L) drop in LDL-C cut major vascular events by about 22%.

What are the side effects of ezetimibe?

In clinical trials, ezetimibe's side effects were only slightly more common than with placebo. The ones that showed up more often were upper respiratory infections, diarrhea, joint pain, sinusitis, limb pain, fatigue, and flu.

Here's how often each happened in the label's 10 placebo-controlled trials, which included 2,396 people taking ezetimibe:

Source: Table 1 of the Zetia prescribing information, revised February 2024 (DailyMed). Most gaps between the two columns are a percentage point or less.

A few less common effects are worth knowing:

• Liver enzymes. Taken with a statin, consecutive liver enzyme rises (to 3 times the upper limit of normal) happened in 1.3% of people, compared with 0.4% on a statin alone. Your clinician may check liver tests when it's clinically indicated.
• Muscle problems. The label warns that ezetimibe may cause myopathy and, rarely, rhabdomyolysis (serious muscle breakdown). In post-marketing reports, most people who developed rhabdomyolysis were also taking a statin or a fibrate. Unexplained muscle pain, weakness, or dark urine is a reason to call.
• Allergic reactions. Rash, hives, swelling (angioedema), and anaphylaxis have been reported. Swelling of the face, lips, or throat, or trouble breathing, needs emergency care.

If muscle aches are the reason you're looking at ezetimibe in the first place, our statin side effects guide explains how to tell a true statin reaction from other causes.

How do you take ezetimibe, and what should you avoid?

The dose is one 10 mg tablet once a day, at any time, with or without food. The main things to avoid are taking it too close to a bile acid binder and starting it with certain other drugs without your clinician knowing.

From the label's drug interaction section (DailyMed):

• Bile acid binders (cholestyramine and similar): take ezetimibe at least 2 hours before or 4 hours after, since cholestyramine lowers how much ezetimibe you absorb.
• Cyclosporine: the combination raises levels of both drugs, so cyclosporine levels need monitoring.
• Fibrates: fenofibrate is studied with ezetimibe; other fibrates, such as gemfibrozil, are not recommended with it.

If you miss a dose, take it when you remember, and don't double up. An LDL check is reasonable as early as 4 weeks after starting.

How much does generic ezetimibe cost?

Generic ezetimibe is one of the cheapest cholesterol medicines available. As of October 2026, Mark Cuban Cost Plus Drugs lists 30 tablets of ezetimibe 10 mg at $6.38, plus $5.25 standard shipping, against a listed retail price of $113.40 at other pharmacies (Cost Plus Drugs).

Generic ezetimibe and brand-name Zetia contain the same active ingredient, so the generic is the usual choice. Prices change, so check before you fill.

Who is ezetimibe for?

Ezetimibe suits two main groups: people on a statin whose LDL is still above target, and people who can't take a statin or can only take a low dose. It also appears in combination pills such as Nexlizet (bempedoic acid plus ezetimibe), which lowers LDL through the liver and the gut at once.

The 2026 ACC/AHA guideline recommends adding a nonstatin, either ezetimibe or a PCSK9 inhibitor, when LDL stays above goal on a statin, and says that escalation should happen without delay (ACC). The guideline's LDL targets are under 70 mg/dL for people with cardiovascular disease and under 55 mg/dL for those at very high risk.

Which add-on fits depends on the gap. If your LDL needs to drop 15 to 20%, ezetimibe often closes it. If it needs to drop by half, a PCSK9 inhibitor is more likely to get you there.

For people who can't tolerate statins, ezetimibe is usually paired with something else, such as bempedoic acid (Nexletol), because 18% on its own rarely reaches a target. Our alternatives to statins guide lays out every option.

Where does ezetimibe fit in step therapy?

Insurance plans usually require prior authorization for a PCSK9 inhibitor such as Repatha or Praluent, and their criteria often ask what lipid-lowering medicines you've already tried. Ezetimibe counts as one of those medicines, which is why it so often shows up as a step before a PCSK9 inhibitor.

For example, one 2026 commercial policy describes "maximally tolerated lipid-lowering therapy (e.g., ezetimibe, statins)" in its PCSK9 criteria (MGB Health Plan policy). The 2026 guideline lists ezetimibe and PCSK9 inhibitors as options at the same stage, but plan policies don't always update as quickly as guidelines do. In practice, a documented ezetimibe trial (the dose, how long, and your LDL on it) is often what turns a prior authorization from "denied" to "approved." Our Repatha cost guide walks through how prior authorization works.

How Preval Health helps

Preval Health focuses only on prescription cholesterol care. A board-certified preventive cardiologist writes our treatment protocols, and licensed clinicians prescribe through our partner telehealth network.

If ezetimibe fits, a partner clinician prescribes it and we recheck your labs, so you know within weeks whether it closed the gap. If it didn't, we move to the next step, such as a PCSK9 inhibitor through a manufacturer cash program, with no prior authorization to wait on. If statins are the problem, see our statin intolerance program, and if you're already past ezetimibe, see how to get a PCSK9 inhibitor prescription online. Either way, care costs $99 a month, and medicines cost extra at cash prices.